News - Cell Signaling Technology
IPSWICH, Mass., April 12, 2011 /PRNewswire/ -- New England Biolabs (NEB), a world leader in the production and supply of reagents for life science research, announces that it has signed exclusive distribution agreements with BIOKE, based in the Netherlands, and Imperial Life Sciences (ILS), based in India.
FREDERICK, Md., July 27 /PRNewswire/ -- Prolias Technologies, Inc., a life science reagent and services company with a focus on supplying cancer researchers with the highest quality research reagents and unmatched customer service, announced today that it has spun out of Prolias, LLC and become its own entity.
In a significant breakthrough, Cell Signaling Technology (CST) (http://www.cellsignal.com) is publishing several papers describing how researchers look inside cancer cells at the complex cell circuitry that drives malignancies.
A new report from Biocompare, Inc., "2007 Antibody Report: Current Trends and Future Outlook," based on a survey of over 800 researchers, finds that 60% expect to increase the number of antibody-based applications performed over the next 12 months.
